Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Lessons From Lockdown: Caring for Patients With Hepatitis B Virus Infection in the COVID-19 Era—Audio Recap

In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and improving care of patients with HBV infection during the COVID-19 pandemic in the United States and Asia, with lessons for around the world.
Norah Terrault Headshot
Norah Terrault, MD, MPH
Grace LH Wong, MD
Released: February 24, 2022

In this episode, Drs Norah Terrault, MD, MPH, and Grace LH Wong, MD, share lessons learned in the care of patients with hepatitis B virus (HBV) in the COVID-19 era, including:

  • HBV cascade of care before vs during the pandemic
  • Innovative strategies to improve HBV diagnosis and linkage to care
  • Lessons learned in telemedicine
  • Elimination through vaccination
  • Management of HBV and COVID-19 coinfection
  • Management of elevated liver enzymes in COVID-19

Information on this Educational Activity


Norah Terrault, MD, MPH

Professor of Medicine
Chief of Gastrointestinal and Liver Diseases
University of Southern California
Los Angeles, California

Norah Terrault, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, GlaxoSmithKline, and Roche/Genentech.
Grace LH Wong, MD

Director, Medical Data Analytics Centre (MDAC)
Deputy Director, Center for Liver Health
Assistant Dean (Learning Experience), Faculty of Medicine
The Chinese University of Hong Kong
Honorary Consultant
Division of Gastroenterology and Hepatology
Department of Medicine and Therapeutics
Prince of Wales Hospital
Hong Kong

Grace LH Wong, MD, has disclosed that she has received funds for research support from AbbVie and Gilead Sciences, consulting fees from Gilead Sciences and Janssen, and fees for non-CME/CE services from Abbott, AbbVie, Bristol-Myers Squibb, Echosens, Furui, Gilead Sciences, Janssen, and Roche.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grants provided by:
Gilead Sciences, Inc.

Related Content

Professor Graham Foster shares his approach to the management of hepatitis B in older adults, from Clinical Care Options (CCO)

Graham R. Foster, FRCP, PhD Released: November 18, 2022

Expert selections of important viral hepatitis data from AASLD 2022, including studies of patients with HBV, HDV, and HCV, from Clinical Care Options (CCO)

Nancy Reau, MD Stefan Zeuzem, MD Released: November 16, 2022

Expert summaries of key data in older patients with HBV, from Clinical Care Options (CCO)

Graham R. Foster, FRCP, PhD Nancy Reau, MD Released: November 16, 2022

Patient advocates and healthcare provider discuss barriers to HBV screening and diagnosis among African immigrants in the US and offer insights and practical solutions for how to improve these practices

person default Janet Afoakwah, MPH person default William Amiteye Patricia D. Jones, MD, MSCR Released: November 14, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings